![Timothy Pearson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Pearson
Directeur Général chez
Carrick Therapeutics Ltd.
Fortune : - $ au 31/05/2026
Profil
Timothy R.
Pearson is Chief Executive Officer at Carrick Therapeutics, Inc. since 2019 and Chief Executive Officer at Carrick Therapeutics UK Ltd. since 2019.
Since 2023, serves as Independent Director at Korro Bio, Inc. Former roles include Director at Xencor, Inc.; Independent Director at RA Pharmaceuticals, Inc. from 2016 to 2020; Independent Director at GlycoMimetics, Inc. from 2014 to 2019; Assistant Treasurer at Integrated Health Services, Inc.; Chief Financial Officer & Executive Vice President at MedImmune LLC in 2011; Chief Financial Officer, Treasurer, EVP & Head-IR at Catalyst Health Solutions, Inc. from 2011 to 2012; Chief Financial & Accounting Officer, Executive VP at Tesaro, Inc. from 2017 to 2019; Commercial Lending Officer at Allfirst Bank (Baltimore, Maryland); and Treasury Manager at CIGNA Insurance Co. of North America (UK) Ltd. Education includes graduate studies at Loyola University Maryland, Inc., and undergraduate studies at the University of Delaware and the University of Maryland University College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Timothy Pearson
| Sociétés | Poste | Début |
|---|---|---|
Carrick Therapeutics Ltd.
 Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Directeur Général | 01/06/2019 |
Carrick Therapeutics UK Ltd.
 Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of cancer therapies | Directeur Général | 01/07/2019 |
Anciens postes connus de Timothy Pearson
| Sociétés | Poste | Fin |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/04/2020 |
| TESARO INC | Directeur Financier/CFO | 01/02/2019 |
Catalyst Health Solutions, Inc.
 Catalyst Health Solutions, Inc. Internet Software/ServicesTechnology Services Provides pharmacy benefit management services | Directeur Financier/CFO | 02/07/2012 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur Financier/CFO | 01/08/2011 |
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Président | - |
Formation de Timothy Pearson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Integrated Health Services, Inc.
 Integrated Health Services, Inc. Hospital/Nursing ManagementHealth Services Provides post-acute healthcare services | Health Services |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Catalyst Health Solutions, Inc.
Catalyst Health Solutions, Inc. Internet Software/ServicesTechnology Services Provides pharmacy benefit management services | Technology Services |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Loyola University Maryland, Inc.
 Loyola University Maryland, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Allfirst Bank (Baltimore, Maryland)
 Allfirst Bank (Baltimore, Maryland) Regional BanksFinance State chartered commercial bank | Finance |
CIGNA Insurance Co. of North America (UK) Ltd. | |
University of Maryland University College
 University of Maryland University College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Health Technology |
Carrick Therapeutics UK Ltd.
Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of cancer therapies | Commercial Services |
